000			01462 a2200385 4500
005			20250516015435.0
264		0	_c20110328
008			201103s 0 0 eng d
022			_a1744-8336
024	7		_a10.1586/eri.10.156 _2doi
040			_aNLM _beng _cNLM
100	1		_aJaiyeoba, Oluwatosin
245	0	0	_aRecommendations and rationale for the treatment of pelvic inflammatory disease. _h[electronic resource]
260			_bExpert review of anti-infective therapy _cJan 2011
300			_a61-70 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aCenters for Disease Control and Prevention, U.S.
650	0	4	_aChlamydia Infections _xdrug therapy
650	0	4	_aChlamydia trachomatis _xdrug effects
650	0	4	_aFemale
650	0	4	_aGonorrhea _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMycoplasma Infections _xdrug therapy
650	0	4	_aMycoplasma genitalium _xdrug effects
650	0	4	_aNeisseria gonorrhoeae _xdrug effects
650	0	4	_aPelvic Inflammatory Disease _xdrug therapy
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aUnited States
700	1		_aLazenby, Gweneth
700	1		_aSoper, David E
773	0		_tExpert review of anti-infective therapy _gvol. 9 _gno. 1 _gp. 61-70
856	4	0	_uhttps://doi.org/10.1586/eri.10.156 _zAvailable from publisher's website
999			_c20460195 _d20460195